Why Cholera Persists In Haiti Despite An Abundance Of Aid

It's been more than three years since cholera struck Haiti. And the epidemic continues today. The deadly bacteria have killed more than 8,500 people and infected hundreds of thousands. Why has the outbreak been so hard to stop, even with more than $9 million in foreign aid pledged to Haiti? Lack of sanitation, says journalist Jonathan Katz, who has been covering the cholera epidemic since it began.

Haiti doesn't have sewers. Instead, the country relies on what's known as the bayakou: independent, and somewhat secretive, laborers who clean the cesspools under people's latrines.


Fighting Cholera With Mass Vaccination

When studying bacteria it is quite easy to get fascinated with them as a laboratory specimen while forgetting the huge impact they can have in real life societies. I find the PLoS journal of Neglected Tropical diseases redresses that as it covers work with bacteria and parasites from the front line. My previous post from this journal was about how bacteria were stored and cultured in non-laboratory conditions, including in remote areas where bacterial infections can have the most impact.


Médecins Sans Frontières (MSF) Scientific Day

Once a year, Médecins Sans Frontières/Doctors Without Borders (MSF) holds MSF Scientific Day – a conference to present scientific research carried out in our programmes around the world.

The next MSF Scientific Day will be streamed live on 23rd May 2014 from the Royal Society of Medicine (RSM) in London.


Epidemiological Update Cholera

Situation summary of cholera in the Americas 
In Cuba, the International Health Regulations National Focal Point (IHR NFP) reported that 23 
additional confirmed cholera cases were registered through the investigation of suspected 
cases between epidemiological week (EW) 35 of 2013 and EW 8 of 2014. In total, 701 cholera 
cases, including three deaths, have been registered since the beginning of the outbreak in EW 
27 of 2012 through EW 8 of 2014. 

140 000 personnes vaccinées contre le choléra au Soudan du Sud

L’Organisation mondiale de la Santé (OMS) travaille avec les autorités sud-soudanaises et les partenaires pour fournir des vaccins destinés à protéger contre le choléra près de 140 000 personnes vivant dans des camps provisoires au Soudan du Sud.
Les vaccins proviennent d’un stock d’urgence géré par l’OMS, la Fédération internationale des Sociétés de la Croix-Rouge et du Croissant-Rouge (FICR), Médecins sans Frontières (MSF) et l’UNICEF. C’est la première fois que cette réserve, créée en 2013 par l’OMS, est activée.

No more needles: Startups design better vaccines

The Bill and Melinda Gates Foundation reports that immunization has led to the eradication of smallpox, a 74 percent reduction in childhood deaths from measles over the past decade, and the near-eradication of polio. But children in developing countries are still in dire need of vaccines, which are not only expensive but require refrigeration, making them difficult to preserve in the poorest parts of the world.

Before cholera kills more in Kano

The outbreak of cholera in Kano State and some states in the North have become a source of concern to people in the state, more so when the disease was reported to have claimed many lives. KOLA OYELERE reports that poor personal hygiene and untidy habits of many in Kano metropolis were largely responsible for the outbreak.

WHEN it was first reported in the media that an outbreak of cholera had spread like wildfire in Kano State, many did not take it seriously, because they never expected that it would cause such a huge mortality among the residents of the state.


Haïti-Choléra : Le Mspp alerte sur des foyers actifs dans cinq départements

Les populations de dix-sept communes, dans les départements géographiques de l’Ouest (où se trouve la capitale Port-au-Prince), de l’Artibonite, du Centre, du Sud-Est et du Sud, sont appelés à rester vigilantes, en raison de la présence de foyers actifs de l’épidémie de choléra, alerte le ministère de la santé publique et de la population (Mspp), en conférence de presse le lundi 20 janvier 2014.


Positive interim results for PaxVax cholera study

PaxVax, Inc., a Menlo Park, California-based vaccine developer, announced positive interim results on Thursday for the Phase III cholera challenge study of its PXVX0200 vaccine candidate.
The study investigated the rate of diarrhea in participants vaccinated with PXVX0200 compared with individuals receiving only the placebo. Twenty of 33 participants receiving the placebo experienced moderate-to-severe diarrhea compared to just two of 35 participants who received PXVX0200.

Fresh typhoid outbreak hits Zimbabwe

The latest weekly surveillance report from the Ministry of Health and Child Care, show that 28 cases of typhoid have been reported countrywide, 13 of these in Harare alone.